Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Sell
43
GSK Quote, Financials, Valuation and Earnings
Last price:
$37.50
Seasonality move
:
1.71%
Day range:
$37.48 - $39.23
52-week range:
$31.72 - $45.93
Dividend yield:
4%
P/E ratio:
20.15x
P/S ratio:
2.00x
P/B ratio:
4.31x
Volume:
2.8M
Avg. volume:
5.9M
1-year change:
-10.69%
Market cap:
$79B
Revenue:
$40.1B
EPS (TTM):
$1.93
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31.3B | $34B | $36.3B | $37.7B | $40.1B | |
| Revenue Growth (YoY) | -27.48% | 8.7% | 6.88% | 3.92% | 6.26% | |
| Cost of Revenues | $10.2B | $11.2B | $11.8B | $10.7B | $11.6B | |
| Gross Profit | $21.1B | $22.7B | $24.5B | $27.1B | $28.5B | |
| Gross Profit Margin | 67.44% | 66.95% | 67.42% | 71.76% | 71.16% | |
| R&D Expenses | $6.2B | $6.9B | $6.8B | $7.7B | $8.2B | |
| Selling, General & Admin | $9.5B | $9.7B | $10.4B | $11.7B | $14.1B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $15.2B | $16B | $16.1B | $17.9B | $21.5B | |
| Operating Income | $5.9B | $6.7B | $8.3B | $9.1B | $7.1B | |
| Net Interest Expenses | $1.1B | $1B | $1B | $914.6M | $770.7M | |
| EBT. Incl. Unusual Items | $6.6B | $5B | $7B | $7.5B | $4.4B | |
| Earnings of Discontinued Ops. | $1.6B | $2.2B | $13.3B | -- | -- | |
| Income Tax Expense | $86M | $114.2M | $875.5M | $940.7M | $672.2M | |
| Net Income to Company | $6.5B | $4.8B | $6.1B | $6.6B | $3.8B | |
| Minority Interest in Earnings | -$820.1M | -$978.2M | -$823.5M | -$472.8M | -$480.5M | |
| Net Income to Common Excl Extra Items | $7.4B | $6B | $18.5B | $6.1B | $3.3B | |
| Basic EPS (Cont. Ops) | $3.71 | $3.02 | $9.20 | $3.03 | $1.62 | |
| Diluted EPS (Cont. Ops) | $3.66 | $2.98 | $9.07 | $2.98 | $1.59 | |
| Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
| Weighted Average Diluted Share | $2B | $2B | $2B | $2.1B | $2.1B | |
| EBITDA | $10.4B | $8.9B | $10.7B | $11.3B | $8.5B | |
| EBIT | $7.7B | $6B | $8B | $8.4B | $5.3B | |
| Revenue (Reported) | $31.3B | $34B | $36.3B | $37.7B | $40.1B | |
| Operating Income (Reported) | $5.9B | $6.7B | $8.3B | $9.1B | $7.1B | |
| Operating Income (Adjusted) | $7.7B | $6B | $8B | $8.4B | $5.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.2B | $9.6B | $8.4B | $9.3B | $9.5B | |
| Revenue Growth (YoY) | -12.23% | -5.66% | -12.42% | 10.54% | 1.33% | |
| Cost of Revenues | $3.4B | $3.6B | $2.4B | $2.5B | $2.4B | |
| Gross Profit | $6.8B | $6B | $6.1B | $6.8B | $7B | |
| Gross Profit Margin | 66.57% | 62.21% | 72.05% | 73.25% | 74.23% | |
| R&D Expenses | $1.5B | $1.5B | $1.5B | $1.8B | $1.8B | |
| Selling, General & Admin | $3.3B | $2.4B | $2.6B | $2.6B | $2.6B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $4.5B | $2.9B | $3.6B | $5B | $4.2B | |
| Operating Income | $2.3B | $3.1B | $2.5B | $1.9B | $2.8B | |
| Net Interest Expenses | $263.3M | $265.7M | $211.5M | $170M | $136M | |
| EBT. Incl. Unusual Items | $2.1B | $2.8B | $2.3B | $1.7B | $2.7B | |
| Earnings of Discontinued Ops. | -- | $531.3M | -- | -- | -- | |
| Income Tax Expense | $355.7M | $433.4M | $335.5M | $347.5M | $423.1M | |
| Net Income to Company | $1.7B | $2.4B | $2B | $1.4B | $2.2B | |
| Minority Interest in Earnings | -$257.8M | -$489.7M | -$171.4M | -$44.4M | -$186.4M | |
| Net Income to Common Excl Extra Items | $1.5B | $2.4B | $1.8B | $1.3B | $2B | |
| Basic EPS (Cont. Ops) | $0.74 | $1.20 | $0.89 | $0.65 | $1.00 | |
| Diluted EPS (Cont. Ops) | $0.73 | $1.19 | $0.89 | $0.64 | $0.99 | |
| Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
| Weighted Average Diluted Share | $2B | $2B | $2B | $2.1B | $2.1B | |
| EBITDA | $2.9B | $3.6B | $3.3B | $2.6B | $3.9B | |
| EBIT | $2.4B | $3.1B | $2.6B | $1.9B | $2.9B | |
| Revenue (Reported) | $10.2B | $9.6B | $8.4B | $9.3B | $9.5B | |
| Operating Income (Reported) | $2.3B | $3.1B | $2.5B | $1.9B | $2.8B | |
| Operating Income (Adjusted) | $2.4B | $3.1B | $2.6B | $1.9B | $2.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $29.5B | $36.5B | $35B | $38.6B | $40.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.4B | $12.6B | $10.6B | $10.8B | $11.5B | |
| Gross Profit | $20.1B | $23.9B | $24.5B | $27.8B | $28.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.2B | $6.9B | $6.8B | $8B | $8.2B | |
| Selling, General & Admin | $9B | $10.1B | $10.5B | $11.7B | $14.1B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $14.7B | $15.8B | $16.6B | $19.3B | $20.8B | |
| Operating Income | $5.4B | $8.1B | $7.8B | $8.5B | $8B | |
| Net Interest Expenses | $1.1B | $1B | $965M | $872M | $736.3M | |
| EBT. Incl. Unusual Items | $6.2B | $6.4B | $6.5B | $6.9B | $5.3B | |
| Earnings of Discontinued Ops. | -- | $2.2B | $12.1B | -- | -- | |
| Income Tax Expense | $215.7M | $333.9M | $799.4M | $952.3M | $742.1M | |
| Net Income to Company | $6.1B | $5.5B | $5.7B | $6B | $4.6B | |
| Minority Interest in Earnings | -$931.4M | -$689.6M | -$535.3M | -$344.1M | -$623.1M | |
| Net Income to Common Excl Extra Items | $6.8B | $6.5B | $17.4B | $5.6B | $4B | |
| Basic EPS (Cont. Ops) | $3.41 | $3.49 | $8.51 | $2.78 | $1.95 | |
| Diluted EPS (Cont. Ops) | $3.37 | $3.45 | $8.39 | $2.75 | $1.93 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $11.8B | $10.4B | $10.6B | $10.6B | $9.8B | |
| EBIT | $7.3B | $7.4B | $7.5B | $7.8B | $6.2B | |
| Revenue (Reported) | $29.5B | $36.5B | $35B | $38.6B | $40.2B | |
| Operating Income (Reported) | $5.4B | $8.1B | $7.8B | $8.5B | $8B | |
| Operating Income (Adjusted) | $7.3B | $7.4B | $7.5B | $7.8B | $6.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.2B | $9.6B | $8.4B | $9.3B | $9.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.4B | $3.6B | $2.4B | $2.5B | $2.4B | |
| Gross Profit | $6.8B | $6B | $6.1B | $6.8B | $7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.5B | $1.5B | $1.5B | $1.8B | $1.8B | |
| Selling, General & Admin | $3.3B | $2.4B | $2.6B | $2.6B | $2.6B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $4.5B | $2.9B | $3.6B | $5B | $4.2B | |
| Operating Income | $2.3B | $3.1B | $2.5B | $1.9B | $2.8B | |
| Net Interest Expenses | $263.3M | $265.7M | $211.5M | $170M | $136M | |
| EBT. Incl. Unusual Items | $2.1B | $2.8B | $2.3B | $1.7B | $2.7B | |
| Earnings of Discontinued Ops. | -- | $531.3M | -- | -- | -- | |
| Income Tax Expense | $355.7M | $433.4M | $335.5M | $347.5M | $423.1M | |
| Net Income to Company | $1.7B | $2.4B | $2B | $1.4B | $2.2B | |
| Minority Interest in Earnings | -$257.8M | -$489.7M | -$171.4M | -$44.4M | -$186.4M | |
| Net Income to Common Excl Extra Items | $1.5B | $2.4B | $1.8B | $1.3B | $2B | |
| Basic EPS (Cont. Ops) | $0.74 | $1.20 | $0.89 | $0.65 | $1.00 | |
| Diluted EPS (Cont. Ops) | $0.73 | $1.19 | $0.89 | $0.64 | $0.99 | |
| Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
| Weighted Average Diluted Share | $2B | $2B | $2B | $2.1B | $2.1B | |
| EBITDA | $2.9B | $3.6B | $3.3B | $2.6B | $3.9B | |
| EBIT | $2.4B | $3.1B | $2.6B | $1.9B | $2.9B | |
| Revenue (Reported) | $10.2B | $9.6B | $8.4B | $9.3B | $9.5B | |
| Operating Income (Reported) | $2.3B | $3.1B | $2.5B | $1.9B | $2.8B | |
| Operating Income (Adjusted) | $2.4B | $3.1B | $2.6B | $1.9B | $2.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.3B | $5.5B | $4.3B | $3.5B | $4.6B | |
| Short Term Investments | $106.3M | $82.3M | $5B | $2.9B | $26.4M | |
| Accounts Receivable, Net | $7.6B | $8.4B | $6.6B | $7.5B | $7B | |
| Inventory | $8.2B | $7.8B | $6.2B | $7B | $7.1B | |
| Prepaid Expenses | $489.3M | $425.1M | $415.1M | $452.2M | $489.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $27.6B | $25.2B | $25.1B | $23.8B | $21.3B | |
| Property Plant And Equipment | $15B | $14.4B | $11.6B | $12.7B | $12.6B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $14.4B | $14.2B | $8.5B | $8.7B | $8.8B | |
| Other Intangibles | $40.6B | $40.6B | $17.3B | $18.8B | $19.5B | |
| Other Long-Term Assets | -- | -- | -- | -- | $2.4B | |
| Total Assets | $109.6B | $106.8B | $72.8B | $75.2B | $74.6B | |
| Accounts Payable | $5.9B | $6.1B | $4.7B | $4.7B | $4.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $313.5M | $274M | $202.1M | $198.7M | $210.8M | |
| Other Current Liabilities | $1B | $1.3B | $1.6B | $1.3B | $1.5B | |
| Total Current Liabilities | $30.2B | $31.9B | $27.6B | $26.8B | $27.2B | |
| Long-Term Debt | $30.7B | $26.7B | $19.6B | $18B | $17.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $81.3B | $78B | $60.6B | $58.9B | $58.2B | |
| Common Stock | $1.8B | $1.8B | $1.6B | $1.7B | $1.7B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $19.9B | $20.3B | $12.8B | $17B | $17.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.5B | $8.5B | -$607.5M | -$703.2M | -$734.1M | |
| Total Equity | $28.4B | $28.8B | $12.2B | $16.3B | $16.4B | |
| Total Liabilities and Equity | $109.6B | $106.8B | $72.8B | $75.2B | $74.6B | |
| Cash and Short Terms | $8.4B | $5.6B | $9.3B | $6.4B | $4.7B | |
| Total Debt | $35.5B | $31.3B | $24.2B | $21.4B | $19.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6.5B | $14.4B | $3.6B | $3.5B | $5.8B | |
| Short Term Investments | $82.5M | $4B | $5.1B | $1.6B | $27.2M | |
| Accounts Receivable, Net | $8.9B | $10.9B | $8.5B | $8.6B | $9.1B | |
| Inventory | $8.5B | $7.9B | $6.6B | $7.2B | $7.8B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $25.5B | $38.1B | $24.4B | $21.7B | $23.4B | |
| Property Plant And Equipment | $14.6B | $14.1B | $11.7B | $12.5B | $12.9B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $14.4B | $14.1B | $8.5B | $8.8B | $9B | |
| Other Intangibles | $40.4B | $40B | $17.5B | $19.8B | $21B | |
| Other Long-Term Assets | $1.4B | $2.4B | $1.9B | $2.1B | $2.6B | |
| Total Assets | $107.3B | $117.8B | $72.6B | $73.9B | $78.5B | |
| Accounts Payable | $20.1B | $23.1B | $17.7B | $18.5B | $19.6B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1B | $1.3B | $1.2B | $1.4B | $1.5B | |
| Total Current Liabilities | $27.9B | $31.9B | $25.6B | $25.1B | $26.9B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $78.4B | $88.1B | $58.6B | $57.2B | $60.9B | |
| Common Stock | $1.9B | $1.8B | $1.7B | $1.7B | $1.7B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.4B | $8.5B | -$629.2M | -$771.4M | -$650.7M | |
| Total Equity | $28.9B | $29.7B | $14B | $16.7B | $17.7B | |
| Total Liabilities and Equity | $107.3B | $117.8B | $72.6B | $73.9B | $78.5B | |
| Cash and Short Terms | $6.6B | $18.4B | $8.6B | $5.2B | $5.8B | |
| Total Debt | $36B | $43.8B | $25.9B | $22.4B | $23.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.5B | $4.8B | $6.1B | $6.6B | $3.8B | |
| Depreciation & Amoritzation | $2.6B | $2.9B | $2.7B | $2.9B | $3.3B | |
| Stock-Based Compensation | $432.5M | $471.9M | $428.5M | $382M | $439.6M | |
| Change in Accounts Receivable | -$806M | -$1.6B | -$762.8M | -$807.6M | $434.5M | |
| Change in Inventories | $128.3M | $70.2M | -$333.1M | -$527.6M | -$375.7M | |
| Cash From Operations | $10.8B | $10.9B | $9.2B | $8.4B | $8.4B | |
| Capital Expenditures | $2.5B | $3.7B | $2.8B | $2.9B | $3.8B | |
| Cash Acquisitions | $3.7B | $254.5M | -$3.9B | $362.1M | $1.7B | |
| Cash From Investing | $2.8B | -$2.4B | -$10.9B | -$2B | -$1.6B | |
| Dividends Paid (Ex Special Dividend) | -$5.1B | -$5.5B | -$4.3B | -$2.8B | -$3.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.2B | $414.1M | $2.5B | $277.5M | $1.7B | |
| Long-Term Debt Repaid | -$9.4B | -$3.2B | -$8.3B | -$3.2B | -$3.2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$866.3M | -$572.3M | $13B | $424.3M | $176.4M | |
| Cash From Financing | -$13B | -$10.4B | $1B | -$7B | -$6B | |
| Beginning Cash (CF) | $6.2B | $7.2B | $4.7B | $4.3B | $3.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $603.2M | -$1.9B | -$676.1M | -$582.3M | $765.5M | |
| Ending Cash (CF) | $6.8B | $5.3B | $4.2B | $3.6B | $4.3B | |
| Levered Free Cash Flow | $8.3B | $7.3B | $6.4B | $5.5B | $4.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.7B | $2.4B | $2B | $1.4B | $2.2B | |
| Depreciation & Amoritzation | $497.6M | $560.8M | $777.9M | $696.3M | $1B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $456.3M | $3.4B | $64.4M | $1.2B | $1.4B | |
| Capital Expenditures | $488M | $764.8M | $643M | $714.1M | $564.1M | |
| Cash Acquisitions | -$117.2M | -$93.9M | -$63.2M | $395.7M | -$1B | |
| Cash From Investing | -$66.2M | -$4.8B | -$495.9M | -$189M | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -$1.3B | -$1.3B | -$674.6M | -$720.4M | -$770.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $2.6B | |
| Long-Term Debt Repaid | -$6.9M | -- | -$175M | -$409.7M | -$200.2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$311M | |
| Other Financing Activities | -$82.7M | $12.6B | $158M | $48.2M | -$36.5M | |
| Cash From Financing | -$1.9B | $10.7B | -$386.5M | -$1.3B | $1.1B | |
| Beginning Cash (CF) | $7.3B | $5.1B | $4.2B | $3.6B | $4.3B | |
| Foreign Exchange Rate Adjustment | -$48.2M | $16.1M | -$37.7M | -$24.1M | -$13.9M | |
| Additions / Reductions | -$1.5B | $9.3B | -$818M | -$318.4M | $1.1B | |
| Ending Cash (CF) | $5.7B | $14.4B | $3.3B | $3.3B | $5.4B | |
| Levered Free Cash Flow | -$31.7M | $2.6B | -$578.6M | $501M | $877.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.1B | $5.5B | $5.7B | $6B | $4.6B | |
| Depreciation & Amoritzation | $2.9B | $3B | $2.9B | $2.8B | $3.6B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.1B | $13.9B | $5.8B | $9.6B | $8.6B | |
| Capital Expenditures | $2.5B | $3.9B | $2.7B | $3B | $3.7B | |
| Cash Acquisitions | $3.4B | $277.8M | -$3.9B | $821M | $312.6M | |
| Cash From Investing | $2.8B | -$7.2B | -$6.5B | -$1.7B | -$2.8B | |
| Dividends Paid (Ex Special Dividend) | -$5.2B | -$5.5B | -$3.7B | -$2.8B | -$3.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.2B | -- | -- | $277.5M | -- | |
| Long-Term Debt Repaid | -$9.3B | -$3.2B | -$8.4B | -$3.5B | -$3B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.3B | $12.1B | $530.4M | $314.5M | $91.7M | |
| Cash From Financing | -$13.6B | $2.2B | -$10.1B | -$8B | -$3.6B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$717.6M | $8.8B | -$10.8B | -$82.7M | $2.2B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $7.5B | $10B | $3.1B | $6.6B | $4.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.7B | $2.4B | $2B | $1.4B | $2.2B | |
| Depreciation & Amoritzation | $497.6M | $560.8M | $777.9M | $696.3M | $1B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $456.3M | $3.4B | $64.4M | $1.2B | $1.4B | |
| Capital Expenditures | $488M | $764.8M | $643M | $714.1M | $564.1M | |
| Cash Acquisitions | -$117.2M | -$93.9M | -$63.2M | $395.7M | -$1B | |
| Cash From Investing | -$66.2M | -$4.8B | -$495.9M | -$189M | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -$1.3B | -$1.3B | -$674.6M | -$720.4M | -$770.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $2.6B | |
| Long-Term Debt Repaid | -$6.9M | -- | -$175M | -$409.7M | -$200.2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$311M | |
| Other Financing Activities | -$82.7M | $12.6B | $158M | $48.2M | -$36.5M | |
| Cash From Financing | -$1.9B | $10.7B | -$386.5M | -$1.3B | $1.1B | |
| Beginning Cash (CF) | $7.3B | $5.1B | $4.2B | $3.6B | $4.3B | |
| Foreign Exchange Rate Adjustment | -$48.2M | $16.1M | -$37.7M | -$24.1M | -$13.9M | |
| Additions / Reductions | -$1.5B | $9.3B | -$818M | -$318.4M | $1.1B | |
| Ending Cash (CF) | $5.7B | $14.4B | $3.3B | $3.3B | $5.4B | |
| Levered Free Cash Flow | -$31.7M | $2.6B | -$578.6M | $501M | $877.6M | |
Get GSK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GSK
Sector
P/E ratio
20.15x
24.03x
PEG ratio
--
0.00x
P/B ratio
4.31x
1.68x
Price / LTM sales
2.00x
1.61x
Growth Metrics
GSK
Sector
Revenue growth
1.33%
5.64%
Earnings growth
53.6%
7.69%
Revenue (5-year growth)
-1.43%
8.27%
Earnings forecast
$1.04
-$0.20
Profitability
GSK
Sector
Profitability FY 2024
$28.5B
$54.2M
Return on invested capital
10.19%
-14.62%
Return on assets
5.26%
-11.9%
Return on equity
23.08%
-17.27%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
30
Estimated Next Earnings Date
Jul
30
Balance Sheet
GSK
Sector
Total cash
$5.8B
$40.4M
Short term investments
$26.4M
$34.9M
Total assets
$74.6B
$120.5M
Long term debt
$23.8B
$9.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
